TY - JOUR
T1 - Chromatin-bound CRM1 recruits SET-Nup214 and NPM1c onto HOX clusters causing aberrant HOX expression in leukemia cells
AU - Oka, Masahiro
AU - Mura, Sonoko
AU - Otani, Mayumi
AU - Miyamoto, Yoichi
AU - Nogami, Jumpei
AU - Maehara, Kazumitsu
AU - Harada, Akihito
AU - Tachibana, Taro
AU - Yoneda, Yoshihiro
AU - Ohkawa, Yasuyuki
N1 - Funding Information:
We thank Dr. Koichi Kawakami for Tol2 transposon-based vectors, Dr. Hitoshi Niwa for ES cell lines, and Drs. Haruhiko Koseki, Shinsuke Ito, and Ichiro Hiratani for valuable discussions. This work was supported in part by JSPS KAKENHI grant numbers 16K14676 and 17H03679 (to MO), 25116008 and 16H04789 (to YY and MO), 19H05244, 18H05527, 18H04802, and 17H03608 (to YO), JST CREST (JPMJCR16G1) (to YO), by a research grant from Japan Leukemia Research Fund (to MO) and Hoan-sha Foundation (to MO).
Publisher Copyright:
© Oka et al.
PY - 2019/11
Y1 - 2019/11
N2 - We previously demonstrated that CRM1, a major nuclear export factor, accumulates at Hox cluster regions to recruit nucleoporin-fusion protein Nup98HoxA9, resulting in robust activation of Hox genes (Oka et al., 2016). However, whether this phenomenon is general to other leukemogenic proteins remains unknown. Here, we show that two other leukemogenic proteins, nucleoporin-fusion SET-Nup214 and the NPM1 mutant, NPM1c, which contains a nuclear export signal (NES) at its C-terminus and is one of the most frequent mutations in acute myeloid leukemia, are recruited to the HOX cluster region via chromatin-bound CRM1, leading to HOX gene activation in human leukemia cells. Furthermore, we demonstrate that this mechanism is highly sensitive to a CRM1 inhibitor in leukemia cell line. Together, these findings indicate that CRM1 acts as a key molecule that connects leukemogenic proteins to aberrant HOX gene regulation either via nucleoporin-CRM1 interaction (for SET-Nup214) or NES-CRM1 interaction (for NPM1c).
AB - We previously demonstrated that CRM1, a major nuclear export factor, accumulates at Hox cluster regions to recruit nucleoporin-fusion protein Nup98HoxA9, resulting in robust activation of Hox genes (Oka et al., 2016). However, whether this phenomenon is general to other leukemogenic proteins remains unknown. Here, we show that two other leukemogenic proteins, nucleoporin-fusion SET-Nup214 and the NPM1 mutant, NPM1c, which contains a nuclear export signal (NES) at its C-terminus and is one of the most frequent mutations in acute myeloid leukemia, are recruited to the HOX cluster region via chromatin-bound CRM1, leading to HOX gene activation in human leukemia cells. Furthermore, we demonstrate that this mechanism is highly sensitive to a CRM1 inhibitor in leukemia cell line. Together, these findings indicate that CRM1 acts as a key molecule that connects leukemogenic proteins to aberrant HOX gene regulation either via nucleoporin-CRM1 interaction (for SET-Nup214) or NES-CRM1 interaction (for NPM1c).
UR - http://www.scopus.com/inward/record.url?scp=85075466728&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075466728&partnerID=8YFLogxK
U2 - 10.7554/eLife.46667
DO - 10.7554/eLife.46667
M3 - Article
C2 - 31755865
AN - SCOPUS:85075466728
SN - 2050-084X
VL - 8
JO - eLife
JF - eLife
M1 - e46667
ER -